Revati Shreeniwas
Overview
Explore the profile of Revati Shreeniwas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siegel M, Garber M, Spencer A, Botwick W, Kumar P, Williams R, et al.
Dig Dis Sci
. 2011 Sep;
57(2):440-50.
PMID: 21948339
Background: Celiac disease is the most common hereditary autoimmune disease in humans. The only treatment option for non-refractory celiac disease patients is adherence to a strict life-long gluten-free diet, which...
2.
Tye-Din J, Anderson R, Ffrench R, Brown G, Hodsman P, Siegel M, et al.
Clin Immunol
. 2009 Nov;
134(3):289-95.
PMID: 19942485
Effective treatment of celiac disease is an unmet medical need. A glutenase that destroys immunogenic gluten peptides may be clinically valuable. Twenty patients with celiac disease were randomly assigned to...
3.
Kefford R, Beith J, Van Hazel G, Millward M, Trotter J, Wyld D, et al.
Invest New Drugs
. 2006 Oct;
25(3):247-52.
PMID: 17021960
There is no effective systemic therapy for disseminated metastatic melanoma. Data suggest that endothelin may play a role in pathophysiology of melanoma and that the dual endothelin receptor antagonist bosentan...
4.
Ellenbogen K, ONeill G, Prystowsky E, Camm J, Meng L, Lieu H, et al.
Circulation
. 2005 Jun;
111(24):3202-8.
PMID: 15956124
Background: Tecadenoson is a potent selective A1-adenosine receptor agonist with a dose-dependent negative dromotropic effect on the AV node. Tecadenoson terminates induced paroxysmal supraventricular tachycardia (PSVT) without the clinically significant...
5.
Morse M, Garst J, Osada T, Khan S, Hobeika A, Clay T, et al.
J Transl Med
. 2005 Feb;
3(1):9.
PMID: 15723705
BACKGROUND: There is a continued need to develop more effective cancer immunotherapy strategies. Exosomes, cell-derived lipid vesicles that express high levels of a narrow spectrum of cell proteins represent a...
6.
Prystowsky E, Niazi I, Curtis A, Wilber D, Bahnson T, Ellenbogen K, et al.
J Am Coll Cardiol
. 2003 Sep;
42(6):1098-102.
PMID: 13678937
Objectives: The aim of this study was to evaluate tecadenoson safety and efficacy during conversion of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm. Background: Tecadenoson (CVT-510), a novel adenosine receptor...
7.
Dhalla A, Shryock J, Shreeniwas R, Belardinelli L
Curr Top Med Chem
. 2003 Feb;
3(4):369-85.
PMID: 12570756
Adenosine's diverse physiological functions are mediated by four subtypes of receptors (A(1), A(2A), A(2B) and A(3)). The A(1) adenosine receptor pharmacology and therapeutic application of ligands for this receptor are...